Search hospitals

>

Nebraska

>

Omaha

University of Nebraska Medical Center

Claim this profile

Omaha, Nebraska 68105

Global Leader in Cancer

Global Leader in Lymphoma

Conducts research for Lung Cancer

Conducts research for Breast Cancer

Conducts research for Leukemia

1232 reported clinical trials

94 medical researchers

Photo of University of Nebraska Medical Center in OmahaPhoto of University of Nebraska Medical Center in Omaha

Summary

University of Nebraska Medical Center is a medical facility located in Omaha, Nebraska. This center is recognized for care of Cancer, Lymphoma, Lung Cancer, Breast Cancer, Leukemia and other specialties. University of Nebraska Medical Center is involved with conducting 1,232 clinical trials across 1,408 conditions. There are 94 research doctors associated with this hospital, such as Jill C. Beck, Minnie Abromowitch, Jonathan Thompson, MD, and Matthew Lunning, DO.

Area of expertise

1

Cancer

Global Leader

University of Nebraska Medical Center has run 167 trials for Cancer. Some of their research focus areas include:

Stage IV
HER2 negative
ER positive
2

Lymphoma

Global Leader

University of Nebraska Medical Center has run 105 trials for Lymphoma. Some of their research focus areas include:

Stage IV
Stage III
Stage II

Top PIs

Clinical Trials running at University of Nebraska Medical Center

Cancer

Skin Cancer

Lung Cancer

Breast Cancer

Breast cancer

Prostate Cancer

Cervical Cancer

Testicular cancer

Brain Tumor

Multiple Myeloma

Image of trial facility.

CCS1477

for Blood Cancers

A Phase 1/2a study to assess the safety, tolerability, PK and biological activity of CCS1477 (inobrodib) in patients with Non-Hodgkin Lymphoma, Multiple Myeloma, Acute Myeloid Leukaemia or High Risk Myelodysplastic syndrome.

Recruiting

3 awards

Phase 1 & 2

5 criteria

Image of trial facility.

Chemotherapy

for Cancer

This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.

Recruiting

2 awards

Phase 3

26 criteria

Image of trial facility.

Immunotherapy + Chemotherapy

for Sarcoma

This phase III trial compares the effect of immunotherapy (pembrolizumab) plus chemotherapy (doxorubicin) to chemotherapy (doxorubicin) alone in treating patients with dedifferentiated liposarcoma (DDLPS), undifferentiated pleomorphic sarcoma (UPS) or a related poorly differentiated sarcoma that has spread from where it first started (primary site) to other places in the body (metastatic) or that cannot be removed by surgery (unresectable). Doxorubicin is in a class of medications called anthracyclines. Doxorubicin damages the cell's deoxyribonucleic acid (DNA) and may kill tumor cells. It also blocks a certain enzyme needed for cell division and DNA repair. A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Adding immunotherapy (pembrolizumab) to the standard chemotherapy (doxorubicin) may help patients with metastatic or unresectable DDLPS, UPS or a related poorly differentiated sarcoma live longer without having disease progression.

Recruiting

2 awards

Phase 3

10 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at University of Nebraska Medical Center?

Where is University of Nebraska Medical Center located?

Who should I call to ask about financial aid or insurance network?

What insurance does University of Nebraska Medical Center accept?

What awards or recognition has University of Nebraska Medical Center received?